PURCHASE AND SALE AGREEMENT THIS PURCHASE AND SALE AGREEMENT (the "Agreement"), is made and entered into as of the 30th day of March, 1999 by and between Prairie View Jack, Ltd., a Minnesota limited partnership (hereinafter called "Seller"), and...Purchase and Sale Agreement • May 14th, 1999 • Surmodics Inc • Adhesives & sealants • Minnesota
2,000,000 SHARES SURMODICS, INC. COMMON STOCK $0.05 PAR VALUEUnderwriting Agreement • December 24th, 1997 • Surmodics Inc • Minnesota
SURMODICS, INC. RESTRICTED STOCK AGREEMENT/_______________________Restricted Stock Agreement • December 24th, 1997 • Surmodics Inc • Minnesota
FORM OF LICENSE AGREEMENT THIS AGREEMENT by and between SurModics, Inc., a corporation of the State of Minnesota, which has an office at 9924 West 74th Street, Eden Prairie, MN 55344, (hereinafter referred to as SURMODICS), and ZZ, a corporation of...License Agreement • December 24th, 1997 • Surmodics Inc
ARTICLE 1 DEFINITIONSLicense Agreement • December 24th, 1997 • Surmodics Inc • Minnesota
OFFICE/WAREHOUSE LEASE THIS INDENTURE of lease, dated this 18th day of November, 1991, by and between Prairieview Jack, Ltd., AmberJack, Ltd., its General Partner, Welsh Companies, Inc., its Manager hereinafter referred to as "Lessor", and Bio-Metric...Lease Agreement • December 24th, 1997 • Surmodics Inc
SURMODICS, INC. and FIRSTAR BANK MILWAUKEE, N.A. as Rights AgentRights Agreement • April 5th, 1999 • Surmodics Inc • Adhesives & sealants • Minnesota
James C. Powell President & Chief Operating Officer SurModics, Inc. (952) 829-2700 MOTOROLA BIOCHIP SYSTEMS AND SURMODICS SIGN GENOMICS-RELATED LICENSE AND DEVELOPMENT AGREEMENT NORTHBROOK, Illinois and EDEN PRAIRIE, Minnesota -- July 6, 2000 --...License and Development Agreement • July 12th, 2000 • Surmodics Inc • Adhesives & sealants
Exhibit 10.1 Seller: Seagate Technology LLC -------------------------- Buyer: DRB #10, LLC -------------------------- Purchase Price: $7,150.00 ------------------------- Agreement Date: August 15, 2001 -------------------------- Earnest Money:...Purchase Agreement • February 14th, 2002 • Surmodics Inc • Adhesives & sealants
FORM OF CHANGE OF CONTROL AGREEMENTChange of Control Agreement • February 7th, 2020 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
2,000,000 SHARES SURMODICS, INC. COMMON STOCK $0.05 PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • February 5th, 1998 • Surmodics Inc • Adhesives & sealants • Minnesota
NONQUALIFIED STOCK OPTION AGREEMENT SURMODICS, INC. 2003 EQUITY INCENTIVE PLANNonqualified Stock Option Agreement • March 20th, 2006 • Surmodics Inc • Patent owners & lessors
THIS AGREEMENT, made effective as of this ___day of ___, ___, by and between SurModics, Inc., a Minnesota corporation (the “Company”), and ______ (“Participant”).
EXHIBIT 10.12 REAGENT SUPPLY AGREEMENT THIS AGREEMENT (the "Reagent Supply Agreement") is made as of the 1st day of January, 2003 Agreement Effective Date") by and between SurModics, Inc., a corporation under the laws of the State of Minnesota...Reagent Supply Agreement • December 30th, 2002 • Surmodics Inc • Adhesives & sealants • Illinois
Exhibit 10.2 NOVOCELL, INC. SERIES C PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES C REFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is made as of December 10, 2001 between Novocell, Inc., a Delaware corporation (the "Company"), and the...Series C Preferred Stock Purchase Agreement • February 14th, 2002 • Surmodics Inc • Adhesives & sealants • California
FIFTH ADDENDUM TO LEASELease • April 26th, 2023 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
THIS FIFTH ADDENDUM TO LEASE (“Fifth Addendum”) is entered into as of the 24th day of February, 2023 (“Effective Date”), by and between MN Golden 1, LLC and MN Golden 2, LLC (as tenants in common), both being Minnesota limited liability companies (collectively, “Landlord”), and Surmodics, Inc., a Minnesota corporation (“Tenant”).
AMENDMENT TO CHANGE OF CONTROL AGREEMENTChange of Control Agreement • December 11th, 2009 • Surmodics Inc • Pharmaceutical preparations
THIS AMENDMENT to the Change of Control Agreement dated April 19, 2006 (the “Agreement”) is made effective December 23, 2008 by and between SurModics, Inc. (the “Company”) and Philip D. Ankeny (“Executive”).
DATED 20 NOVEMBER 2015 PUT AND CALL OPTION AGREEMENT RELATING TO SHARES IN CREAGH MEDICAL LIMITED LKG SOLICITORS The Forum Glasthule Co. Dublin TEL + 353 1 2311430 FAX + 353 1 2311417 E-Mail: neilk@lkgsolicitors.ie Web: www.lkgsolicitors.iePut and Call Option Agreement • November 27th, 2015 • Surmodics Inc • Surgical & medical instruments & apparatus
B The Optionee and the Grantors have agreed to grant to each other the respective options hereinafter described in respect of the Shares (as hereinafter defined) on the terms and conditions hereinafter contained.
SurModics, Inc. Restricted Stock Unit Award Agreement (Non-Employee Director)Restricted Stock Unit Award Agreement • May 8th, 2014 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
SurModics, Inc. (the “Company”), pursuant to Section 8 of its 2009 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this restricted stock unit Award are set forth in this Restricted Stock Unit Award Agreement (the “Agreement”), consisting of this cover page and the Terms and Conditions on the following pages, and in the Plan document which has been provided to you. To the extent any capitalized term used in this Agreement is not defined, it shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.
SECOND AMENDMENT TO CHANGE OF CONTROL AGREEMENTChange of Control Agreement • December 11th, 2009 • Surmodics Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT to the Change of Control Agreement dated April 19, 2006 (the “Agreement”) is made effective April 19, 2009, by and between SurModics, Inc. (the “Company”) and Philip D. Ankeny (“Executive”).
SECOND AMENDMENT TO CHANGE OF CONTROL AGREEMENTChange of Control Agreement • April 22nd, 2009 • Surmodics Inc • Pharmaceutical preparations
THIS SECOND AMENDMENT to the Change of Control Agreement dated April 19, 2006 (the “Agreement”) is made effective April 19, 2009, by and between SurModics, Inc. (the “Company”) and Bruce J Barclay (“Executive”).
SURMODICS, INC. NONQUALIFIED STOCK OPTION THIS AGREEMENT, made this ________ day of _________________, 19____ by and between SurModics, Inc., a Minnesota corporation (the "Company"), and ,(the "Optionee"); W I T N E S S E T H: WHEREAS, on or before on...Nonqualified Stock Option Agreement • December 24th, 1997 • Surmodics Inc
CREDIT AGREEMENT by and between SURMODICS., INC. and WELLS FARGO BANK, NATIONAL ASSOCIATION, as Sole Lead Arranger and Administrative Agent and the Lenders party hereto Dated as of February 27, 2009Credit Agreement • March 4th, 2009 • Surmodics Inc • Pharmaceutical preparations • Minnesota
This Credit Agreement, together with all exhibits and schedules attached hereto and hereby made a part hereof (“Agreement”), is made as of February 27, 2009, by and among SurModics, Inc., a Minnesota corporation (the “Borrower”), the financial institutions from time to time party hereto (the “Lenders”) and Wells Fargo Bank, National Association, a national banking association (in its individual capacity, “Wells Fargo”), and Wells Fargo as sole lead arranger and as administrative agent for the Lenders (in such administrative agent capacity, the “Agent”).
Re: Separation Agreement and ReleaseSeparation Agreement • May 10th, 2011 • Surmodics Inc • Pharmaceutical preparations • Minnesota
As we have discussed, your employment with SurModics, Inc., including its subsidiary SurModics Pharmaceuticals, Inc. (“SurModics”), will end effective February 16, 2011. The purpose of this Separation Agreement and Release letter (“Agreement”) is to set forth the specific separation pay and benefits that SurModics will provide you in exchange for your agreement to the terms and conditions of this Agreement.
SURMODICS, INC. Restricted Stock Unit Award Agreement (Director)Restricted Stock Unit Award Agreement • May 6th, 2019 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
SurModics, Inc. (the “Company”), pursuant to its 2019 Equity Incentive Plan (the “Plan”), hereby grants an award of Restricted Stock Units to you, the Participant named below. The terms and conditions of this Award are set forth in this Restricted Stock Unit Award Agreement (the “Agreement”), consisting of this cover page and the Terms and Conditions on the following pages, and in the Plan document, a copy of which has been provided to you. Any capitalized term that is used but not defined in this Agreement shall have the meaning assigned to it in the Plan as it currently exists or as it is amended in the future.
SURMODICS, INC. RESTRICTED STOCK AGREEMENT*Restricted Stock Agreement • February 4th, 2015 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
This is a Restricted Stock Agreement (“Agreement”) between SurModics, Inc., a Minnesota corporation (the “Company”), and the Participant identified in the table above.
THIRD AMENDMENT TO CREDIT AGREEMENTCredit Agreement • February 5th, 2016 • Surmodics Inc • Surgical & medical instruments & apparatus
This Third Amendment to Credit Agreement (this “Third Amendment”) is entered into as of December 22, 2015 (the “Third Amendment Effective Date”), by and between WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”) and SURMODICS, INC., a Minnesota corporation (“Borrower”).
AMENDMENT TOChange of Control Agreement • February 13th, 2015 • Surmodics Inc • Surgical & medical instruments & apparatus
THIS AMENDMENT TO CHANGE OF CONTROL AGREEMENT is made effective February 9, 2015, by and between SurModics, Inc. (the “Company”) and Bryan K. Phillips (“Executive”).
SurModics, Inc.Deferred Stock Unit Master Agreement • February 4th, 2015 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
This is a Deferred Stock Unit Master Agreement (the “Agreement”) between SurModics, Inc., a Minnesota corporation (the “Company”), and you,. Any capitalized term used but not defined in this Agreement shall have the meaning set forth in the Company’s 2009 Equity Incentive Plan as it currently exists or as it is amended in the future (the “Plan”).
OMNIBUS AMENDMENT TO CERTAIN EQUITY AGREEMENTS WITH NON-EMPLOYEE DIRECTORSEquity Award Amendment • May 8th, 2014 • Surmodics Inc • Surgical & medical instruments & apparatus
This OMNIBUS AMENDMENT (the “Amendment”) is between SurModics, Inc., a Minnesota corporation (the “Company”), and *[Participant Name] (the “Participant”) amends certain equity award agreements previously entered into between the Company and Participant under the terms of the Company’s 2009 Equity Incentive Plan (the “Plan”). All capitalized terms in this Amendment, to the extent not otherwise defined herein, shall have the meanings assigned to them in the Plan.
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 15th, 2020 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
THIS LOAN AND SECURITY AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”), dated as of September 14, 2020, is by and among SURMODICS, INC., a Minnesota corporation (“Borrower”), the other Loan Parties hereto, and BRIDGEWATER BANK, a Minnesota banking corporation (together with its successors and assigns, “Lender”).
May 31, 2017Credit Agreement • August 3rd, 2017 • Surmodics Inc • Surgical & medical instruments & apparatus
Reference is made to that certain Amended and Restated Credit Agreement dated as of November 2, 2016, (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) by and among SURMODICS, INC. (the “Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (the “Bank”). Except as otherwise provided herein, capitalized terms used in this letter shall have the meanings given to them in the Credit Agreement.
INCENTIVE STOCK OPTION AGREEMENT SURMODICS, INC. 2003 EQUITY INCENTIVE PLANIncentive Stock Option Agreement • March 20th, 2006 • Surmodics Inc • Patent owners & lessors
THIS AGREEMENT, made effective as of this ___day of _________, ______, by and between SurModics, Inc., a Minnesota corporation (the “Company”), and ____________(“Participant”).
MERGER AGREEMENT among BCE PARENT, LLC (“Parent”) BCE MERGER SUB, INC. (“Merger Sub”) and SURMODICS, INC. (the “Company”) Dated as of May 28, 2024Merger Agreement • May 29th, 2024 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
This Merger Agreement (this “Agreement”) is dated as of May 28, 2024 among BCE Parent, LLC, a Delaware limited liability company (“Parent”), BCE Merger Sub, Inc., a Minnesota corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Surmodics, Inc., a Minnesota corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the meaning set forth in Exhibit A attached hereto. This Agreement is a plan of merger within the meaning of the Minnesota Business Corporation Act, Chapter 302A of the Minnesota Statutes (the “MBCA”).
EXHIBIT 10.11 ADJUSTED LICENSE AGREEMENT THIS AGREEMENT, dated January 1, 2003, by and between SurModics, Inc., a corporation of the State of Minnesota, which has an office at 9924 West 74th Street, Eden Prairie, MN 55344, (hereinafter referred to as...Adjusted License Agreement • December 30th, 2002 • Surmodics Inc • Adhesives & sealants
AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • November 7th, 2016 • Surmodics Inc • Surgical & medical instruments & apparatus • Minnesota
THIS AMENDED AND RESTATED CREDIT AGREEMENT (this “Agreement”) is entered into as of November 2, 2016 (the “Restatement Date”), by and between SURMODICS, INC., a Minnesota corporation (“Borrower”), and WELLS FARGO BANK, NATIONAL ASSOCIATION (“Bank”). Capitalized terms used herein and not otherwise defined shall have the meanings given to them in the Revolving Line of Credit Note (as defined below).
